A Review of Lysergic Acid Diethylamide (LSD) in the Treatment of Addictions: Historical Perspectives and Future Prospects
Current Drug Abuse Reviews January 9, 2015 DOI: 10.2174/1874473708666150107120522 (opens in new tab)
Study at a glance
AI-extracted from the abstractAbstract
Lysergic acid diethylamide (LSD) is a semisynthetic compound with strong psychoactive properties. Chemically related to serotonin, LSD was initially hypothesized to produce a psychosislike state. Later, LSD was reported to have benefits in the treatment of addictions. However, widespread indiscriminate use and reports of adverse affects resulted in the classification of LSD as an illicit drug with no accepted medical use. This article reviews LSD's storied history from its discovery, to its use as a research tool, followed by its widespread association with the counterculture movement of the 1960s, and finally to its rebirth as a medicine with potential benefits in the treatment of addictions. LSD's pharmacology, phenomenology, effects at neurotransmitter receptors, and effects on patterns of gene expression are reviewed. Based upon a review of the literature, it is concluded that further research into LSD's potential as a treatment for addictions is warranted.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
Reviews LSD's history and pharmacology and concludes that further research into LSD's potential as a treatment for addictions is warranted.
Synthesized
Comparable studies
Other narrative reviews on LSD for addiction, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function. General population | 2019 | Integrative review | |
| Psychedelic Drugs in Biomedicine | 2017 | Review | |
| The Past and Future of Psychedelic Science: An Introduction to This Issue | 2019 | Review | |
| Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD) | 2018 | Review | |
| Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders | 2022 | Review |
Citations in the library
Cited by 30
- Global Street Food: la cocina de la calle Diseño interior 2009
- Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years Therapeutic Advances in Psychopharmacology March 18, 2016
- Therapeutic Use of LSD in Psychiatry: A Systematic Review of Randomized-Controlled Clinical Trials Frontiers in Psychiatry January 21, 2020
- Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders Molecules April 13, 2022
- Methylenedioxymethamphetamine (MDMA) in Psychiatry Journal of Clinical Psychopharmacology October 10, 2018
and 25 more in the library
Cites 24
- Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents. Life Sciences December 17, 1984
- Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials Journal of Psychopharmacology March 8, 2012
- Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada Current Drug Abuse Reviews June 1, 2013
- Response of cluster headache to psilocybin and LSD Neurology June 26, 2006
- A Single Dose of Lysergic Acid Diethylamide Influences Gene Expression Patterns within the Mammalian Brain Neuropsychopharmacology May 1, 2002
and 19 more in the library